107 results on '"Coughlan JJ"'
Search Results
2. 27 A Systematic review of the evidence supporting the use of surgical aortic and mitral valves: an update from the core MD consortium
3. 16 Treatment intensity of lipid lowering therapy in high- and very high-risk patients for the prevention of cardiovascular events – baseline characteristics from the Irish cohort of the multinational, observational Santorini study
4. 57 GLU298ASP variant of the endothelial nitric oxide synthase gene and acute coronary syndrome or premature coronary artery disease: a systematic review and meta-analysis
5. Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis
6. Noise in medical decision making: a silent epidemic?
7. 9 Target vessel and non-target vessel related events at 10 years post percutaneous coronary intervention
8. 52 Long-term clinical outcomes after drug eluting stent implantation with and without stent overlap
9. The diagnostic yield of transthoracic echocardiography in the intensive care unit: A retrospective observational analysis
10. Contemporary Management of Isolated Ostial Side Branch Disease: An Evidence-based Approach to Medina 001 Bifurcations
11. 2 A hierarchal analysis of eligibility for PCSK9 inhibition in Ireland: bridging the divide between the NCPE managed access protocol and ESC/EAS guidelines
12. 54 Residual risk in cardiac rehab: can we reduce-it more? Eligibility for icosapent ethyl in patients attending cardiac rehabilitation
13. 61 The effect of covid-19 lockdown on stemi presentations: an early phase analysis
14. 40 Transoesophageal echocardiogram findings in STROKE & TIA, their relationship with MRI DWI lesions
15. 42 The prevalence of takotsubo cardiomyopathy in patients admitted to the intensive care unit
16. 25 Real world prescribing strategies for patients with an indication for oral anticoagulation undergoing percutaneous coronary intervention
17. 60 The correlation between cardiac biomarkers and findings on transthoracic echocardiography in the intensive care unit. A single centre, retrospective study
18. Alternative Access for Transcatheter Aortic Valve Implantation: Current Evidence and Future Directions
19. 18 Rotational atherectomy in the modern cardiac catheterisation laboratory patient demographics, procedural characteristics and clinical outcomes
20. Improving Communication with General Practitioners post ST elevation Myocardial Infarction
21. 49 Prevalence and predictors of qtc prolongation in acute medical admissions
22. Diagnosing, fast and slow
23. 37 Neutrophil to lymphocyte ratio as a predictor of outcomes and plaque burden in ST segment elevation myocardial infraction (STEMI)
24. 27 Early and mid term outcomes after transaortic catheter valve implantation (TAVI): Abstract 27 Table 1
25. PHP42 PHARMACEUTICAL EXPENDITURE AND POTENTIAL AVENUES FOR COST CONTAINMENT IN IRELAND
26. 49 Prevalence and predictors of qtc prolongation in acute medical admissions
27. Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel.
28. An initial invasive strategy in older patients with non-ST elevation acute coronary syndromes: it is never too late.
29. The '10 commandments' for the 2023 ESC Guidelines for the management of acute coronary syndromes.
30. Type of evidence supporting ACC/AHA and ESC clinical practice guidelines for acute coronary syndrome.
31. A systematic assessment of the characteristics of randomized controlled trials cited by acute coronary syndrome clinical practice guidelines.
32. 2023 ESC Guidelines for the management of acute coronary syndromes.
33. Cangrelor to optimise platelet inhibition in STEMI patients pre-treated with ticagrelor: A Sisyphean task?
34. Anaemia in patients with cardiogenic shock complicating acute myocardial infarction: Surrogate marker of poor outcome or therapeutic target?
35. Quality and transparency of evidence for implantable cardiovascular medical devices assessed by the CORE-MD consortium.
36. Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines.
37. 2023 ESC Guidelines for the management of acute coronary syndromes.
38. Glu298Asp variant of the endothelial nitric oxide synthase gene and acute coronary syndrome or premature coronary artery disease: A systematic review and meta-analysis.
39. High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry.
40. Noise in medical decision making: a silent epidemic?
41. The effect of a Prasugrel- vs. a Ticagrelor-based strategy on total ischaemic and bleeding events in patients with acute coronary syndromes.
42. Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
43. Ten-year clinical outcomes of drug-eluting stents with different polymer coating strategies by degree of coronary calcification: a pooled analysis of the ISAR-TEST 4 and 5 randomised trials.
44. Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE Cooperation.
45. Reperfusion in ST-elevation myocardial infarction: delays have dangerous ends.
46. Environmental Sustainability in the Cardiac Catheter Laboratory.
47. The therapeutic benefit of vasodilators in acute heart failure: absence of evidence or evidence of absence?
48. Bivalirudin in patients with ST-segment elevation myocardial infarction.
49. Ten-year patterns of stent thrombosis after percutaneous coronary intervention with new- versus early-generation drug-eluting stents: insights from the DECADE cooperation.
50. Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.